Novel motif:48: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{Novel_motif
|name=motif48_CANTCG
|novel_motifs_human_sample_pval=11376-118A8_11051;0.663474,11327-117E4_11969;0.952072,11473-119C6_11054;0.370346,11474-119C7_12067;0.76651...") |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 14:45, 9 September 2013
name: | motif48_CANTCG |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0071673 | positive regulation of smooth muscle cell chemotaxis | 2.036338e-10 |
GO:0016570 | histone modification | 2.655230e-10 |
GO:0016569 | covalent chromatin modification | 3.669223e-10 |
GO:0006348 | chromatin silencing at telomere | 6.324859e-9 |
GO:0051299 | centrosome separation | 6.940516e-9 |
GO:0071671 | regulation of smooth muscle cell chemotaxis | 8.130447e-9 |
GO:0001757 | somite specification | 1.958976e-8 |
GO:0060764 | cell-cell signaling involved in mammary gland development | 3.267861e-8 |
GO:0033523 | histone H2B ubiquitination | 9.826067e-8 |
GO:0060999 | positive regulation of dendritic spine development | 1.428422e-7 |
GO:0007549 | dosage compensation | 2.096005e-7 |
GO:0006281 | DNA repair | 3.288894e-7 |
GO:0035026 | leading edge cell differentiation | 5.253486e-7 |
GO:0032060 | bleb assembly | 5.853792e-7 |
GO:2000615 | regulation of histone H3-K9 acetylation | 7.317641e-7 |
GO:0060430 | lung saccule development | 7.798340e-7 |
GO:0034227 | tRNA thio-modification | 8.347033e-7 |
GO:0002098 | tRNA wobble uridine modification | 8.347033e-7 |
GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin | 1.278172e-6 |
GO:0060435 | bronchiole development | 1.521001e-6 |
GO:0009048 | dosage compensation, by inactivation of X chromosome | 1.738219e-6 |
GO:0000416 | positive regulation of histone H3-K36 methylation | 1.738219e-6 |
GO:0060482 | lobar bronchus development | 2.016668e-6 |
GO:0042696 | menarche | 3.011241e-6 |
GO:0045820 | negative regulation of glycolysis | 3.205810e-6 |
GO:0070584 | mitochondrion morphogenesis | 3.475668e-6 |
GO:0090399 | replicative senescence | 3.519074e-6 |
GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly | 4.551229e-6 |
GO:0042538 | hyperosmotic salinity response | 4.978622e-6 |
GO:0051457 | maintenance of protein location in nucleus | 5.154460e-6 |
GO:0021759 | globus pallidus development | 5.371169e-6 |
GO:0046950 | cellular ketone body metabolic process | 5.513438e-6 |
GO:0032472 | Golgi calcium ion transport | 5.523275e-6 |
GO:0032468 | Golgi calcium ion homeostasis | 5.523275e-6 |
GO:0030026 | cellular manganese ion homeostasis | 5.523275e-6 |
GO:0060534 | trachea cartilage development | 6.749888e-6 |
GO:0006302 | double-strand break repair | 8.310254e-6 |
GO:2001037 | positive regulation of tongue muscle cell differentiation | 8.408498e-6 |
GO:0060982 | coronary artery morphogenesis | 8.408498e-6 |
GO:0097152 | mesenchymal cell apoptosis | 8.408498e-6 |
GO:0051589 | negative regulation of neurotransmitter transport | 9.065883e-6 |
GO:0046602 | regulation of mitotic centrosome separation | 9.270336e-6 |
GO:0001675 | acrosome assembly | 9.270433e-6 |
GO:0060480 | lung goblet cell differentiation | 1.007628e-5 |
GO:0060260 | regulation of transcription initiation from RNA polymerase II promoter | 1.016176e-5 |
GO:0035356 | cellular triglyceride homeostasis | 1.059083e-5 |
GO:0051154 | negative regulation of striated muscle cell differentiation | 1.157353e-5 |
GO:0043467 | regulation of generation of precursor metabolites and energy | 1.499124e-5 |
GO:0060042 | retina morphogenesis in camera-type eye | 1.691462e-5 |
GO:0006310 | DNA recombination | 1.840355e-5 |
GO:0007379 | segment specification | 1.919937e-5 |
GO:2000620 | positive regulation of histone H4-K16 acetylation | 2.168895e-5 |
GO:2000617 | positive regulation of histone H3-K9 acetylation | 2.168895e-5 |
GO:0070512 | positive regulation of histone H4-K20 methylation | 2.168895e-5 |
GO:0048842 | positive regulation of axon extension involved in axon guidance | 2.188447e-5 |
GO:0070842 | aggresome assembly | 2.245845e-5 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 2.334960e-5 |
GO:0006482 | protein demethylation | 2.667085e-5 |
GO:0045005 | maintenance of fidelity involved in DNA-dependent DNA replication | 2.703481e-5 |
GO:0010225 | response to UV-C | 2.823308e-5 |
GO:0022412 | cellular process involved in reproduction in multicellular organism | 3.054249e-5 |
GO:0060535 | trachea cartilage morphogenesis | 3.163611e-5 |
GO:0031297 | replication fork processing | 3.234890e-5 |
GO:0021892 | cerebral cortex GABAergic interneuron differentiation | 3.238991e-5 |
GO:0016574 | histone ubiquitination | 3.360570e-5 |
GO:0016568 | chromatin modification | 3.368124e-5 |
GO:0051898 | negative regulation of protein kinase B signaling cascade | 3.999040e-5 |
GO:0010890 | positive regulation of sequestering of triglyceride | 4.181994e-5 |
GO:0002016 | regulation of blood volume by renin-angiotensin | 4.382617e-5 |
GO:0051571 | positive regulation of histone H3-K4 methylation | 4.888202e-5 |
GO:0040032 | post-embryonic body morphogenesis | 4.906675e-5 |
GO:0060486 | Clara cell differentiation | 5.268947e-5 |
GO:0048664 | neuron fate determination | 5.268947e-5 |
GO:0060023 | soft palate development | 5.486734e-5 |
GO:0035269 | protein O-linked mannosylation | 5.731060e-5 |
GO:0006400 | tRNA modification | 5.731241e-5 |
GO:0021783 | preganglionic parasympathetic nervous system development | 5.777760e-5 |
GO:0060574 | intestinal epithelial cell maturation | 6.249406e-5 |
GO:0048561 | establishment of organ orientation | 6.378266e-5 |
GO:0046605 | regulation of centrosome cycle | 7.822619e-5 |
GO:0046599 | regulation of centriole replication | 7.932251e-5 |
GO:0060510 | Type II pneumocyte differentiation | 9.166467e-5 |
GO:0060017 | parathyroid gland development | 9.201402e-5 |
GO:0035928 | rRNA import into mitochondrion | 9.242449e-5 |
GO:2000466 | negative regulation of glycogen (starch) synthase activity | 1.019570e-4 |
GO:0042447 | hormone catabolic process | 1.049875e-4 |
GO:0000724 | double-strand break repair via homologous recombination | 1.119337e-4 |
GO:0000725 | recombinational repair | 1.121114e-4 |
GO:0051983 | regulation of chromosome segregation | 1.315434e-4 |
GO:0010830 | regulation of myotube differentiation | 1.335971e-4 |
GO:0060816 | random inactivation of X chromosome | 1.381217e-4 |
GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly | 1.492270e-4 |
GO:0018026 | peptidyl-lysine monomethylation | 1.546752e-4 |
GO:0006288 | base-excision repair, DNA ligation | 1.616130e-4 |
GO:0001302 | replicative cell aging | 1.620152e-4 |
GO:0090346 | cellular organofluorine metabolic process | 1.726128e-4 |
GO:0046210 | nitric oxide catabolic process | 1.726128e-4 |
GO:0043602 | nitrate catabolic process | 1.726128e-4 |
GO:0045685 | regulation of glial cell differentiation | 1.752341e-4 |
GO:0048704 | embryonic skeletal system morphogenesis | 1.850137e-4 |
GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 1.877556e-4 |
GO:0048486 | parasympathetic nervous system development | 1.927819e-4 |
GO:0060876 | semicircular canal formation | 1.951779e-4 |
GO:0009648 | photoperiodism | 1.957521e-4 |
GO:0060059 | embryonic retina morphogenesis in camera-type eye | 1.996762e-4 |
GO:0010390 | histone monoubiquitination | 1.997782e-4 |
GO:0051365 | cellular response to potassium ion starvation | 2.041602e-4 |
GO:0051645 | Golgi localization | 2.041602e-4 |
GO:0016575 | histone deacetylation | 2.062493e-4 |
GO:0016254 | preassembly of GPI anchor in ER membrane | 2.095981e-4 |
GO:0060465 | pharynx development | 2.107803e-4 |
GO:0006013 | mannose metabolic process | 2.161502e-4 |
GO:0015891 | siderophore transport | 2.223391e-4 |
GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 2.281983e-4 |
GO:0061013 | regulation of mRNA catabolic process | 2.287995e-4 |
GO:0000414 | regulation of histone H3-K36 methylation | 2.349214e-4 |
GO:0015820 | leucine transport | 2.548092e-4 |
GO:0045607 | regulation of auditory receptor cell differentiation | 2.561686e-4 |
GO:0034389 | lipid particle organization | 2.572625e-4 |
GO:0048713 | regulation of oligodendrocyte differentiation | 2.612549e-4 |
GO:0048663 | neuron fate commitment | 2.788239e-4 |
GO:0051181 | cofactor transport | 3.085856e-4 |
GO:0021675 | nerve development | 3.098300e-4 |
GO:0002002 | regulation of angiotensin levels in blood | 3.130984e-4 |
GO:0046951 | ketone body biosynthetic process | 3.158820e-4 |
GO:0030421 | defecation | 3.176553e-4 |
GO:0018022 | peptidyl-lysine methylation | 3.179647e-4 |
GO:0021569 | rhombomere 3 development | 3.204431e-4 |
GO:0005981 | regulation of glycogen catabolic process | 3.211246e-4 |
GO:0050847 | progesterone receptor signaling pathway | 3.211246e-4 |
GO:0072303 | positive regulation of glomerular metanephric mesangial cell proliferation | 3.231510e-4 |
GO:0015742 | alpha-ketoglutarate transport | 3.427632e-4 |
GO:0071503 | response to heparin | 3.472405e-4 |
GO:0000413 | protein peptidyl-prolyl isomerization | 3.496093e-4 |
GO:0046952 | ketone body catabolic process | 3.588084e-4 |
GO:0060850 | regulation of transcription involved in cell fate commitment | 3.601496e-4 |
GO:0046293 | formaldehyde biosynthetic process | 3.617633e-4 |
GO:0045608 | negative regulation of auditory receptor cell differentiation | 3.624762e-4 |
GO:0071584 | negative regulation of zinc ion import | 3.819796e-4 |
GO:0090281 | negative regulation of calcium ion import | 3.819796e-4 |
GO:0007100 | mitotic centrosome separation | 3.819796e-4 |
GO:0045819 | positive regulation of glycogen catabolic process | 3.861654e-4 |
GO:0051955 | regulation of amino acid transport | 3.869092e-4 |
GO:0010719 | negative regulation of epithelial to mesenchymal transition | 3.946338e-4 |
GO:0010986 | positive regulation of lipoprotein particle clearance | 3.964890e-4 |
GO:0060347 | heart trabecula formation | 4.019999e-4 |
GO:0046600 | negative regulation of centriole replication | 4.042720e-4 |
GO:0060356 | leucine import | 4.165180e-4 |
GO:0032836 | glomerular basement membrane development | 4.251438e-4 |
GO:0007506 | gonadal mesoderm development | 4.545142e-4 |
GO:0046939 | nucleotide phosphorylation | 4.558982e-4 |
GO:0043457 | regulation of cellular respiration | 4.678169e-4 |
GO:0006844 | acyl carnitine transport | 4.783368e-4 |
GO:0006308 | DNA catabolic process | 4.784677e-4 |
GO:0007344 | pronuclear fusion | 4.993961e-4 |
GO:0060433 | bronchus development | 5.167963e-4 |
GO:0018208 | peptidyl-proline modification | 5.451135e-4 |
GO:0016577 | histone demethylation | 5.499334e-4 |
GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter | 5.568147e-4 |
GO:0070988 | demethylation | 5.570499e-4 |
GO:0048752 | semicircular canal morphogenesis | 5.594658e-4 |
GO:2001014 | regulation of skeletal muscle cell differentiation | 5.712673e-4 |
GO:0043471 | regulation of cellular carbohydrate catabolic process | 5.865529e-4 |
GO:0021895 | cerebral cortex neuron differentiation | 6.205618e-4 |
GO:0010889 | regulation of sequestering of triglyceride | 6.360576e-4 |
GO:0061014 | positive regulation of mRNA catabolic process | 6.531000e-4 |
GO:0045655 | regulation of monocyte differentiation | 6.544051e-4 |
GO:0060487 | lung epithelial cell differentiation | 6.634292e-4 |
GO:0007092 | activation of mitotic anaphase-promoting complex activity | 6.886609e-4 |
GO:0031658 | negative regulation of cyclin-dependent protein kinase activity involved in G1/S | 6.886609e-4 |
GO:0002882 | positive regulation of chronic inflammatory response to non-antigenic stimulus | 6.886609e-4 |
GO:0006044 | N-acetylglucosamine metabolic process | 7.059444e-4 |
GO:0071338 | positive regulation of hair follicle cell proliferation | 7.077078e-4 |
GO:0021819 | layer formation in cerebral cortex | 7.077078e-4 |
GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation | 7.119820e-4 |
GO:0008292 | acetylcholine biosynthetic process | 7.611654e-4 |
GO:0021602 | cranial nerve morphogenesis | 7.634565e-4 |
GO:0071529 | cementum mineralization | 8.014088e-4 |
GO:0018206 | peptidyl-methionine modification | 8.014088e-4 |
GO:0010948 | negative regulation of cell cycle process | 8.023547e-4 |
GO:0061384 | heart trabecular morphogenesis | 8.096310e-4 |
GO:0051569 | regulation of histone H3-K4 methylation | 8.133423e-4 |
GO:0051612 | negative regulation of serotonin uptake | 8.156165e-4 |
GO:0034968 | histone lysine methylation | 8.270196e-4 |
GO:0009886 | post-embryonic morphogenesis | 8.378160e-4 |
GO:0010832 | negative regulation of myotube differentiation | 8.577805e-4 |
GO:0007522 | visceral muscle development | 8.904287e-4 |
GO:0046469 | platelet activating factor metabolic process | 9.004104e-4 |
GO:0031573 | intra-S DNA damage checkpoint | 9.204132e-4 |
GO:0006325 | chromatin organization | 9.250747e-4 |
GO:0006513 | protein monoubiquitination | 9.456788e-4 |
GO:0006047 | UDP-N-acetylglucosamine metabolic process | 9.540061e-4 |
GO:0007141 | male meiosis I | 9.540061e-4 |
GO:0002036 | regulation of L-glutamate transport | 9.798030e-4 |
GO:0051276 | chromosome organization | 9.992279e-4 |
GO:0007569 | cell aging | 1.017547e-3 |
GO:0045657 | positive regulation of monocyte differentiation | 1.025199e-3 |
GO:0043414 | macromolecule methylation | 1.063121e-3 |
GO:2001054 | negative regulation of mesenchymal cell apoptosis | 1.128233e-3 |
GO:0034959 | endothelin maturation | 1.183278e-3 |
GO:0010814 | substance P catabolic process | 1.183278e-3 |
GO:0010816 | calcitonin catabolic process | 1.183278e-3 |
GO:0032581 | ER-dependent peroxisome organization | 1.228570e-3 |
GO:0031576 | G2/M transition checkpoint | 1.277981e-3 |
GO:0007109 | cytokinesis, completion of separation | 1.291324e-3 |
GO:0018198 | peptidyl-cysteine modification | 1.304434e-3 |
GO:0071504 | cellular response to heparin | 1.304434e-3 |
GO:0034766 | negative regulation of ion transmembrane transport | 1.385377e-3 |
GO:0010677 | negative regulation of cellular carbohydrate metabolic process | 1.401601e-3 |
GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair | 1.409712e-3 |
GO:0051029 | rRNA transport | 1.411023e-3 |
GO:0034551 | mitochondrial respiratory chain complex III assembly | 1.411128e-3 |
GO:0072595 | maintenance of protein localization to organelle | 1.433021e-3 |
GO:0045210 | FasL biosynthetic process | 1.531406e-3 |
GO:0097039 | protein linear polyubiquitination | 1.531406e-3 |
GO:0000966 | RNA 5'-end processing | 1.538746e-3 |
GO:0090075 | relaxation of muscle | 1.540375e-3 |
GO:0000072 | M phase specific microtubule process | 1.620757e-3 |
GO:0021517 | ventral spinal cord development | 1.790355e-3 |
GO:0060977 | coronary vasculature morphogenesis | 1.848256e-3 |
GO:0051532 | regulation of NFAT protein import into nucleus | 1.848375e-3 |
GO:0007386 | compartment pattern specification | 1.848375e-3 |
GO:0006501 | C-terminal protein lipidation | 1.850427e-3 |
GO:0043922 | negative regulation by host of viral transcription | 1.850478e-3 |
GO:0032007 | negative regulation of TOR signaling cascade | 1.897099e-3 |
GO:0007296 | vitellogenesis | 1.897099e-3 |
GO:0007097 | nuclear migration | 1.905079e-3 |
GO:0072126 | positive regulation of glomerular mesangial cell proliferation | 1.914101e-3 |
GO:0071506 | cellular response to mycophenolic acid | 1.914101e-3 |
GO:0090239 | regulation of histone H4 acetylation | 1.961299e-3 |
GO:0043153 | entrainment of circadian clock by photoperiod | 1.983169e-3 |
GO:0010771 | negative regulation of cell morphogenesis involved in differentiation | 1.990517e-3 |
GO:0051660 | establishment of centrosome localization | 2.031979e-3 |
GO:0021540 | corpus callosum morphogenesis | 2.031979e-3 |
GO:0060060 | post-embryonic retina morphogenesis in camera-type eye | 2.047982e-3 |
GO:0019358 | nicotinate nucleotide salvage | 2.142526e-3 |
GO:0006479 | protein methylation | 2.201026e-3 |
GO:0097150 | neuronal stem cell maintenance | 2.224056e-3 |
GO:0001921 | positive regulation of receptor recycling | 2.224056e-3 |
GO:0060021 | palate development | 2.250199e-3 |
GO:0090102 | cochlea development | 2.287703e-3 |
GO:0003148 | outflow tract septum morphogenesis | 2.295519e-3 |
GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion | 2.300360e-3 |
GO:0035461 | vitamin transmembrane transport | 2.303205e-3 |
GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment | 2.303205e-3 |
GO:0021893 | cerebral cortex GABAergic interneuron fate commitment | 2.303205e-3 |
GO:0021798 | forebrain dorsal/ventral pattern formation | 2.322574e-3 |
GO:0006476 | protein deacetylation | 2.348175e-3 |
GO:0090307 | spindle assembly involved in mitosis | 2.357836e-3 |
GO:0034699 | response to luteinizing hormone stimulus | 2.361415e-3 |
GO:0035166 | post-embryonic hemopoiesis | 2.401186e-3 |
GO:0000718 | nucleotide-excision repair, DNA damage removal | 2.424680e-3 |
GO:0046292 | formaldehyde metabolic process | 2.472692e-3 |
GO:0060177 | regulation of angiotensin metabolic process | 2.509982e-3 |
GO:0060318 | definitive erythrocyte differentiation | 2.569775e-3 |
GO:0044330 | canonical Wnt receptor signaling pathway involved in positive regulation of wound healing | 2.600688e-3 |
GO:0044328 | canonical Wnt receptor signaling pathway involved in positive regulation of endothelial cell migration | 2.600688e-3 |
GO:0044329 | canonical Wnt receptor signaling pathway involved in positive regulation of cell-cell adhesion | 2.600688e-3 |
GO:0034645 | cellular macromolecule biosynthetic process | 2.602524e-3 |
GO:0021599 | abducens nerve formation | 2.611802e-3 |
GO:0019428 | allantoin biosynthetic process | 2.611802e-3 |
GO:0007634 | optokinetic behavior | 2.611802e-3 |
GO:0070625 | zymogen granule exocytosis | 2.631235e-3 |
GO:0035601 | protein deacylation | 2.635931e-3 |
GO:0001990 | regulation of systemic arterial blood pressure by hormone | 2.660422e-3 |
GO:0006094 | gluconeogenesis | 2.711898e-3 |
GO:0001832 | blastocyst growth | 2.719824e-3 |
GO:0006048 | UDP-N-acetylglucosamine biosynthetic process | 2.842050e-3 |
GO:0002678 | positive regulation of chronic inflammatory response | 2.874276e-3 |
GO:0030953 | astral microtubule organization | 2.877569e-3 |
GO:0070874 | negative regulation of glycogen metabolic process | 2.997766e-3 |
GO:0033683 | nucleotide-excision repair, DNA incision | 2.997766e-3 |
GO:0034447 | very-low-density lipoprotein particle clearance | 3.077069e-3 |
GO:0014053 | negative regulation of gamma-aminobutyric acid secretion | 3.143908e-3 |
GO:0060428 | lung epithelium development | 3.166809e-3 |
GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin | 3.282959e-3 |
GO:0021644 | vagus nerve morphogenesis | 3.387369e-3 |
GO:0043461 | proton-transporting ATP synthase complex assembly | 3.392669e-3 |
GO:0019348 | dolichol metabolic process | 3.392669e-3 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 3.405545e-3 |
GO:0060576 | intestinal epithelial cell development | 3.456690e-3 |
GO:0051103 | DNA ligation involved in DNA repair | 3.456690e-3 |
GO:0002676 | regulation of chronic inflammatory response | 3.499820e-3 |
GO:0034393 | positive regulation of smooth muscle cell apoptosis | 3.544813e-3 |
GO:0090304 | nucleic acid metabolic process | 3.645748e-3 |
GO:0031572 | G2/M transition DNA damage checkpoint | 3.676483e-3 |
GO:0007181 | transforming growth factor beta receptor complex assembly | 3.689890e-3 |
GO:0060872 | semicircular canal development | 3.693500e-3 |
GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation | 3.718281e-3 |
GO:0002689 | negative regulation of leukocyte chemotaxis | 3.720375e-3 |
GO:0015788 | UDP-N-acetylglucosamine transport | 3.803271e-3 |
GO:0007140 | male meiosis | 3.803488e-3 |
GO:0090398 | cellular senescence | 3.815684e-3 |
GO:0060282 | positive regulation of oocyte development | 3.825235e-3 |
GO:0055119 | relaxation of cardiac muscle | 3.933204e-3 |
GO:0007253 | cytoplasmic sequestering of NF-kappaB | 3.997508e-3 |
GO:0007063 | regulation of sister chromatid cohesion | 3.997508e-3 |
GO:0009225 | nucleotide-sugar metabolic process | 4.026949e-3 |
GO:0021681 | cerebellar granular layer development | 4.089446e-3 |
GO:0006335 | DNA replication-dependent nucleosome assembly | 4.100243e-3 |
GO:0000183 | chromatin silencing at rDNA | 4.179965e-3 |
GO:0060087 | relaxation of vascular smooth muscle | 4.225123e-3 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 4.248259e-3 |
GO:0061003 | positive regulation of dendritic spine morphogenesis | 4.248259e-3 |
GO:0051790 | short-chain fatty acid biosynthetic process | 4.322274e-3 |
GO:0006974 | response to DNA damage stimulus | 4.399804e-3 |
GO:0018095 | protein polyglutamylation | 4.418298e-3 |
GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis | 4.464678e-3 |
GO:0071313 | cellular response to caffeine | 4.464678e-3 |
GO:0010983 | positive regulation of high-density lipoprotein particle clearance | 4.464678e-3 |
GO:0035545 | determination of left/right asymmetry in nervous system | 4.464678e-3 |
GO:0021612 | facial nerve structural organization | 4.523010e-3 |
GO:0090136 | epithelial cell-cell adhesion | 4.553361e-3 |
GO:0070384 | Harderian gland development | 4.683849e-3 |
GO:0034498 | early endosome to Golgi transport | 4.683849e-3 |
GO:0031914 | negative regulation of synaptic plasticity | 4.683849e-3 |
GO:0072331 | signal transduction by p53 class mediator | 4.700916e-3 |
GO:0032897 | negative regulation of viral transcription | 4.749976e-3 |
GO:0060479 | lung cell differentiation | 4.751956e-3 |
GO:0050883 | musculoskeletal movement, spinal reflex action | 4.916176e-3 |
GO:0032938 | negative regulation of translation in response to oxidative stress | 4.916176e-3 |
GO:0043171 | peptide catabolic process | 4.958345e-3 |
GO:0015884 | folic acid transport | 4.958345e-3 |
GO:0021528 | commissural neuron differentiation in spinal cord | 4.962325e-3 |
GO:0070159 | mitochondrial threonyl-tRNA aminoacylation | 4.962325e-3 |
GO:0006051 | N-acetylmannosamine metabolic process | 4.962325e-3 |
GO:0021545 | cranial nerve development | 5.012697e-3 |
GO:0018410 | C-terminal protein amino acid modification | 5.085850e-3 |
GO:0007612 | learning | 5.096670e-3 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 5.142651e-3 |
GO:0007207 | activation of phospholipase C activity by muscarinic acetylcholine receptor signaling pathway | 5.312024e-3 |
GO:0030828 | positive regulation of cGMP biosynthetic process | 5.312024e-3 |
GO:0051534 | negative regulation of NFAT protein import into nucleus | 5.505111e-3 |
GO:0070562 | regulation of vitamin D receptor signaling pathway | 5.517328e-3 |
GO:0021570 | rhombomere 4 development | 5.517328e-3 |
GO:0044260 | cellular macromolecule metabolic process | 5.603251e-3 |
GO:0006548 | histidine catabolic process | 5.624337e-3 |
GO:0009059 | macromolecule biosynthetic process | 5.654026e-3 |
GO:0051647 | nucleus localization | 5.656707e-3 |
GO:0014037 | Schwann cell differentiation | 5.722292e-3 |
GO:0014013 | regulation of gliogenesis | 5.723296e-3 |
GO:0007020 | microtubule nucleation | 5.727779e-3 |
GO:0000959 | mitochondrial RNA metabolic process | 5.727779e-3 |
GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly | 5.761478e-3 |
GO:0070127 | tRNA aminoacylation for mitochondrial protein translation | 5.772478e-3 |
GO:0060575 | intestinal epithelial cell differentiation | 5.783830e-3 |
GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline | 5.808334e-3 |
GO:0071585 | detoxification of cadmium ion | 5.840069e-3 |
GO:0072668 | tubulin complex biogenesis | 5.848614e-3 |
GO:0042772 | DNA damage response, signal transduction resulting in transcription | 5.956817e-3 |
GO:0031365 | N-terminal protein amino acid modification | 5.972818e-3 |
GO:0055118 | negative regulation of cardiac muscle contraction | 6.174943e-3 |
GO:0048706 | embryonic skeletal system development | 6.179845e-3 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 6.246013e-3 |
GO:0045719 | negative regulation of glycogen biosynthetic process | 6.277282e-3 |
GO:0018027 | peptidyl-lysine dimethylation | 6.303838e-3 |
GO:0016571 | histone methylation | 6.365720e-3 |
GO:0000075 | cell cycle checkpoint | 6.460044e-3 |
GO:0008033 | tRNA processing | 6.460984e-3 |
GO:0060045 | positive regulation of cardiac muscle cell proliferation | 6.480297e-3 |
GO:0002369 | T cell cytokine production | 6.510659e-3 |
GO:0001963 | synaptic transmission, dopaminergic | 6.555881e-3 |
GO:0071816 | tail-anchored membrane protein insertion into ER membrane | 6.833424e-3 |
GO:0010815 | bradykinin catabolic process | 6.833424e-3 |
GO:0045687 | positive regulation of glial cell differentiation | 6.842329e-3 |
GO:0048714 | positive regulation of oligodendrocyte differentiation | 6.952662e-3 |
GO:0009650 | UV protection | 7.069248e-3 |
GO:0071934 | thiamine transmembrane transport | 7.159067e-3 |
GO:0009159 | deoxyribonucleoside monophosphate catabolic process | 7.159067e-3 |
GO:0035445 | borate transmembrane transport | 7.159067e-3 |
GO:0009401 | phosphoenolpyruvate-dependent sugar phosphotransferase system | 7.159067e-3 |
GO:0016598 | protein arginylation | 7.159067e-3 |
GO:0033233 | regulation of protein sumoylation | 7.166808e-3 |
GO:0018105 | peptidyl-serine phosphorylation | 7.167941e-3 |
GO:0000965 | mitochondrial RNA 3'-end processing | 7.217471e-3 |
GO:0000962 | positive regulation of mitochondrial RNA catabolic process | 7.217471e-3 |
GO:0000958 | mitochondrial mRNA catabolic process | 7.217471e-3 |
GO:0046358 | butyrate biosynthetic process | 7.281477e-3 |
GO:0060580 | ventral spinal cord interneuron fate determination | 7.281477e-3 |
GO:0003327 | type B pancreatic cell fate commitment | 7.281477e-3 |
GO:0071156 | regulation of cell cycle arrest | 7.349508e-3 |
GO:0051488 | activation of anaphase-promoting complex activity | 7.442697e-3 |
GO:0006449 | regulation of translational termination | 7.450039e-3 |
GO:0017004 | cytochrome complex assembly | 7.555361e-3 |
GO:0002367 | cytokine production involved in immune response | 7.724431e-3 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 7.728295e-3 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 7.803288e-3 |
GO:0009451 | RNA modification | 7.817443e-3 |
GO:0051584 | regulation of dopamine uptake | 7.861652e-3 |
GO:0021520 | spinal cord motor neuron cell fate specification | 7.863997e-3 |
GO:0048715 | negative regulation of oligodendrocyte differentiation | 7.930340e-3 |
GO:0032020 | ISG15-protein conjugation | 7.992885e-3 |
GO:0014052 | regulation of gamma-aminobutyric acid secretion | 7.992885e-3 |
GO:0007538 | primary sex determination | 8.094003e-3 |
GO:0061072 | iris morphogenesis | 8.163653e-3 |
GO:0060596 | mammary placode formation | 8.185352e-3 |
GO:0009147 | pyrimidine nucleoside triphosphate metabolic process | 8.263687e-3 |
GO:0060998 | regulation of dendritic spine development | 8.428319e-3 |
GO:0016486 | peptide hormone processing | 8.488818e-3 |
GO:0042228 | interleukin-8 biosynthetic process | 8.513521e-3 |
GO:0035621 | ER to Golgi ceramide transport | 8.513521e-3 |
GO:0043316 | cytotoxic T cell degranulation | 8.609588e-3 |
GO:0001830 | trophectodermal cell fate commitment | 8.609588e-3 |
GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process | 8.614396e-3 |
GO:0035019 | somatic stem cell maintenance | 8.648268e-3 |
GO:0046364 | monosaccharide biosynthetic process | 8.673294e-3 |
GO:0015872 | dopamine transport | 8.712943e-3 |
GO:0072109 | glomerular mesangium development | 8.743948e-3 |
GO:0006659 | phosphatidylserine biosynthetic process | 8.743948e-3 |
GO:0072110 | glomerular mesangial cell proliferation | 8.792856e-3 |
GO:0046349 | amino sugar biosynthetic process | 8.792856e-3 |
GO:0034198 | cellular response to amino acid starvation | 9.066486e-3 |
GO:0006826 | iron ion transport | 9.108553e-3 |
GO:0031860 | telomeric 3' overhang formation | 9.173873e-3 |
GO:0043456 | regulation of pentose-phosphate shunt | 9.173873e-3 |
GO:0016078 | tRNA catabolic process | 9.173873e-3 |
GO:0001682 | tRNA 5'-leader removal | 9.173873e-3 |
GO:0006002 | fructose 6-phosphate metabolic process | 9.326610e-3 |
GO:0035025 | positive regulation of Rho protein signal transduction | 9.378578e-3 |
GO:0048562 | embryonic organ morphogenesis | 9.414130e-3 |
GO:0043441 | acetoacetic acid biosynthetic process | 9.450104e-3 |
GO:0070846 | Hsp90 deacetylation | 9.525683e-3 |
GO:2000252 | negative regulation of feeding behavior | 9.525683e-3 |
GO:0090042 | tubulin deacetylation | 9.525683e-3 |
GO:0006272 | leading strand elongation | 9.525683e-3 |
GO:0016095 | polyprenol catabolic process | 9.525683e-3 |
GO:0018916 | nitrobenzene metabolic process | 9.525683e-3 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 9.630690e-3 |
GO:0014014 | negative regulation of gliogenesis | 9.734245e-3 |
GO:0048073 | regulation of eye pigmentation | 9.839599e-3 |
GO:0009440 | cyanate catabolic process | 9.909469e-3 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 9.909469e-3 |
GO:0045814 | negative regulation of gene expression, epigenetic | 9.947696e-3 |
GO:0003407 | neural retina development | 1.012908e-2 |
GO:0070375 | BMK cascade | 1.033317e-2 |
GO:0006344 | maintenance of chromatin silencing | 1.033317e-2 |
GO:0055014 | atrial cardiac muscle cell development | 1.033317e-2 |
GO:0022027 | interkinetic nuclear migration | 1.036092e-2 |
GO:0021546 | rhombomere development | 1.055372e-2 |
GO:0033861 | negative regulation of NAD(P)H oxidase activity | 1.089057e-2 |
GO:0021903 | rostrocaudal neural tube patterning | 1.098943e-2 |
GO:0016048 | detection of temperature stimulus | 1.117066e-2 |
GO:0072393 | microtubule anchoring at microtubule organizing center | 1.142843e-2 |
GO:0016584 | nucleosome positioning | 1.142843e-2 |
GO:0006269 | DNA replication, synthesis of RNA primer | 1.188818e-2 |
GO:0006261 | DNA-dependent DNA replication | 1.190562e-2 |
GO:0043585 | nose morphogenesis | 1.194976e-2 |
GO:0060976 | coronary vasculature development | 1.221903e-2 |
GO:0090342 | regulation of cell aging | 1.224726e-2 |
GO:0003360 | brainstem development | 1.225338e-2 |
GO:0022601 | menstrual cycle phase | 1.231427e-2 |
GO:0060349 | bone morphogenesis | 1.236731e-2 |
GO:0044027 | hypermethylation of CpG island | 1.242013e-2 |
GO:0060152 | microtubule-based peroxisome localization | 1.242924e-2 |
GO:0070873 | regulation of glycogen metabolic process | 1.258519e-2 |
GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 1.258610e-2 |
GO:0045175 | basal protein localization | 1.283609e-2 |
GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment | 1.284221e-2 |
GO:0035417 | negative regulation of mitotic prometaphase | 1.288920e-2 |
GO:0090234 | regulation of kinetochore assembly | 1.295005e-2 |
GO:0090169 | regulation of spindle assembly | 1.295005e-2 |
GO:0060839 | endothelial cell fate commitment | 1.321874e-2 |
GO:0034501 | protein localization to kinetochore | 1.336710e-2 |
GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process | 1.336710e-2 |
GO:2000772 | regulation of cellular senescence | 1.350976e-2 |
GO:0032205 | negative regulation of telomere maintenance | 1.354900e-2 |
GO:0021522 | spinal cord motor neuron differentiation | 1.355258e-2 |
GO:0031627 | telomeric loop formation | 1.357214e-2 |
GO:0060304 | regulation of phosphatidylinositol dephosphorylation | 1.357214e-2 |
GO:0031119 | tRNA pseudouridine synthesis | 1.357214e-2 |
GO:0030042 | actin filament depolymerization | 1.357214e-2 |
GO:0042274 | ribosomal small subunit biogenesis | 1.362140e-2 |
GO:0001553 | luteinization | 1.374567e-2 |
GO:0045168 | cell-cell signaling involved in cell fate commitment | 1.378342e-2 |
GO:0040030 | regulation of molecular function, epigenetic | 1.386616e-2 |
GO:2000251 | positive regulation of actin cytoskeleton reorganization | 1.386616e-2 |
GO:0006828 | manganese ion transport | 1.414549e-2 |
GO:0050872 | white fat cell differentiation | 1.425554e-2 |
GO:0031570 | DNA integrity checkpoint | 1.431839e-2 |
GO:0010801 | negative regulation of peptidyl-threonine phosphorylation | 1.467370e-2 |
GO:0042136 | neurotransmitter biosynthetic process | 1.468783e-2 |
GO:0018205 | peptidyl-lysine modification | 1.474798e-2 |
GO:0051972 | regulation of telomerase activity | 1.499489e-2 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.515124e-2 |
GO:0050775 | positive regulation of dendrite morphogenesis | 1.527237e-2 |
GO:0042254 | ribosome biogenesis | 1.532753e-2 |
GO:0055021 | regulation of cardiac muscle tissue growth | 1.535825e-2 |
GO:0009651 | response to salt stress | 1.546052e-2 |
GO:0006413 | translational initiation | 1.548273e-2 |
GO:0003310 | pancreatic A cell differentiation | 1.554475e-2 |
GO:0072061 | inner medullary collecting duct development | 1.562448e-2 |
GO:0072060 | outer medullary collecting duct development | 1.562448e-2 |
GO:0000492 | box C/D snoRNP assembly | 1.562448e-2 |
GO:0016332 | establishment or maintenance of polarity of embryonic epithelium | 1.562448e-2 |
GO:0043653 | mitochondrial fragmentation involved in apoptosis | 1.567290e-2 |
GO:0000422 | mitochondrion degradation | 1.567290e-2 |
GO:0090219 | negative regulation of lipid kinase activity | 1.585169e-2 |
GO:0045842 | positive regulation of mitotic metaphase/anaphase transition | 1.588758e-2 |
GO:0015827 | tryptophan transport | 1.588758e-2 |
GO:0051973 | positive regulation of telomerase activity | 1.605713e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0031167 | rRNA methylation | 3.661943e-13 |
GO:0000154 | rRNA modification | 1.950983e-11 |
GO:0022402 | cell cycle process | 3.733648e-9 |
GO:0006396 | RNA processing | 1.114421e-8 |
GO:0016072 | rRNA metabolic process | 1.460524e-8 |
GO:0042254 | ribosome biogenesis | 2.154605e-8 |
GO:0006364 | rRNA processing | 7.512648e-8 |
GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 2.192692e-7 |
GO:0022403 | cell cycle phase | 4.350337e-7 |
GO:0050685 | positive regulation of mRNA processing | 7.934968e-7 |
GO:0050668 | positive regulation of homocysteine metabolic process | 8.050108e-7 |
GO:0045963 | negative regulation of dopamine metabolic process | 8.050108e-7 |
GO:0071843 | cellular component biogenesis at cellular level | 1.306779e-6 |
GO:0022613 | ribonucleoprotein complex biogenesis | 1.469729e-6 |
GO:0030902 | hindbrain development | 1.484355e-6 |
GO:0019255 | glucose 1-phosphate metabolic process | 1.936321e-6 |
GO:0019047 | provirus integration | 1.967026e-6 |
GO:0007049 | cell cycle | 6.174563e-6 |
GO:0000917 | barrier septum formation | 6.501464e-6 |
GO:0032922 | circadian regulation of gene expression | 6.662115e-6 |
GO:0000239 | pachytene | 7.061628e-6 |
GO:0000279 | M phase | 1.154355e-5 |
GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol | 1.192954e-5 |
GO:0015761 | mannose transport | 1.362925e-5 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 1.539904e-5 |
GO:0035282 | segmentation | 2.013668e-5 |
GO:0040029 | regulation of gene expression, epigenetic | 2.231253e-5 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 2.250940e-5 |
GO:0061014 | positive regulation of mRNA catabolic process | 2.295242e-5 |
GO:0006657 | CDP-choline pathway | 3.110970e-5 |
GO:0034446 | substrate adhesion-dependent cell spreading | 3.157415e-5 |
GO:0032446 | protein modification by small protein conjugation | 4.009260e-5 |
GO:0034470 | ncRNA processing | 4.444451e-5 |
GO:0016567 | protein ubiquitination | 4.483084e-5 |
GO:0016331 | morphogenesis of embryonic epithelium | 4.991794e-5 |
GO:0021549 | cerebellum development | 5.291327e-5 |
GO:0090224 | regulation of spindle organization | 5.687580e-5 |
GO:0051176 | positive regulation of sulfur metabolic process | 6.007567e-5 |
GO:0061053 | somite development | 6.838208e-5 |
GO:0042147 | retrograde transport, endosome to Golgi | 7.372936e-5 |
GO:0006306 | DNA methylation | 7.824205e-5 |
GO:0009138 | pyrimidine nucleoside diphosphate metabolic process | 7.856320e-5 |
GO:0007099 | centriole replication | 7.856320e-5 |
GO:0070165 | positive regulation of adiponectin secretion | 8.399503e-5 |
GO:0045362 | positive regulation of interleukin-1 biosynthetic process | 8.399503e-5 |
GO:0070430 | positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 8.399503e-5 |
GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 8.399503e-5 |
GO:0032707 | negative regulation of interleukin-23 production | 8.399503e-5 |
GO:0033031 | positive regulation of neutrophil apoptosis | 8.399503e-5 |
GO:0033617 | mitochondrial respiratory chain complex IV assembly | 8.399503e-5 |
GO:0051586 | positive regulation of dopamine uptake | 8.466149e-5 |
GO:0061013 | regulation of mRNA catabolic process | 8.494301e-5 |
GO:0010870 | positive regulation of receptor biosynthetic process | 1.040454e-4 |
GO:0061386 | closure of optic fissure | 1.069829e-4 |
GO:0035332 | positive regulation of hippo signaling cascade | 1.069829e-4 |
GO:0035148 | tube formation | 1.234254e-4 |
GO:0048704 | embryonic skeletal system morphogenesis | 1.256242e-4 |
GO:0001841 | neural tube formation | 1.368940e-4 |
GO:0072298 | regulation of metanephric glomerulus development | 1.383045e-4 |
GO:0001510 | RNA methylation | 1.429574e-4 |
GO:0032259 | methylation | 1.454355e-4 |
GO:0001555 | oocyte growth | 1.458731e-4 |
GO:0006261 | DNA-dependent DNA replication | 1.550924e-4 |
GO:0006139 | nucleobase-containing compound metabolic process | 1.567049e-4 |
GO:0051225 | spindle assembly | 1.647325e-4 |
GO:0090304 | nucleic acid metabolic process | 1.700409e-4 |
GO:0031440 | regulation of mRNA 3'-end processing | 1.706016e-4 |
GO:0045749 | negative regulation of S phase of mitotic cell cycle | 1.758944e-4 |
GO:0001838 | embryonic epithelial tube formation | 1.765151e-4 |
GO:0022037 | metencephalon development | 1.849580e-4 |
GO:0090286 | cytoskeletal anchoring at nuclear membrane | 1.920600e-4 |
GO:0001756 | somitogenesis | 1.985356e-4 |
GO:0000726 | non-recombinational repair | 2.080747e-4 |
GO:0043414 | macromolecule methylation | 2.109238e-4 |
GO:0060022 | hard palate development | 2.111993e-4 |
GO:0009952 | anterior/posterior pattern specification | 2.177835e-4 |
GO:0048706 | embryonic skeletal system development | 2.233043e-4 |
GO:0045930 | negative regulation of mitotic cell cycle | 2.239902e-4 |
GO:0032418 | lysosome localization | 2.281525e-4 |
GO:0034660 | ncRNA metabolic process | 2.431991e-4 |
GO:0072527 | pyrimidine-containing compound metabolic process | 2.518803e-4 |
GO:0090192 | regulation of glomerulus development | 2.662706e-4 |
GO:0032790 | ribosome disassembly | 2.718188e-4 |
GO:0018242 | protein O-linked glycosylation via serine | 2.942083e-4 |
GO:0018243 | protein O-linked glycosylation via threonine | 2.942083e-4 |
GO:0045666 | positive regulation of neuron differentiation | 2.954538e-4 |
GO:0003002 | regionalization | 3.000390e-4 |
GO:0072175 | epithelial tube formation | 3.072082e-4 |
GO:0006493 | protein O-linked glycosylation | 3.160008e-4 |
GO:0048705 | skeletal system morphogenesis | 3.174013e-4 |
GO:0007128 | meiotic prophase I | 3.200397e-4 |
GO:0060023 | soft palate development | 3.206593e-4 |
GO:2000678 | negative regulation of transcription regulatory region DNA binding | 3.206593e-4 |
GO:0051926 | negative regulation of calcium ion transport | 3.220664e-4 |
GO:0038007 | netrin-activated signaling pathway | 3.380494e-4 |
GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway | 3.380494e-4 |
GO:0016340 | calcium-dependent cell-matrix adhesion | 3.448123e-4 |
GO:0000237 | leptotene | 3.661119e-4 |
GO:0006233 | dTDP biosynthetic process | 3.671890e-4 |
GO:0007346 | regulation of mitotic cell cycle | 3.713796e-4 |
GO:0042637 | catagen | 3.748060e-4 |
GO:0060012 | synaptic transmission, glycinergic | 3.777792e-4 |
GO:0051594 | detection of glucose | 3.833603e-4 |
GO:0043576 | regulation of respiratory gaseous exchange | 4.121939e-4 |
GO:0045764 | positive regulation of cellular amino acid metabolic process | 4.360914e-4 |
GO:0061298 | retina vasculature development in camera-type eye | 4.399264e-4 |
GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway | 5.058557e-4 |
GO:0001839 | neural plate morphogenesis | 5.412579e-4 |
GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 5.412579e-4 |
GO:0060262 | negative regulation of N-terminal protein palmitoylation | 5.488381e-4 |
GO:0001840 | neural plate development | 5.611959e-4 |
GO:0021915 | neural tube development | 5.689231e-4 |
GO:0006011 | UDP-glucose metabolic process | 5.959846e-4 |
GO:0071480 | cellular response to gamma radiation | 6.720399e-4 |
GO:0051298 | centrosome duplication | 6.909889e-4 |
GO:0043117 | positive regulation of vascular permeability | 6.957375e-4 |
GO:0050779 | RNA destabilization | 7.063858e-4 |
GO:0042420 | dopamine catabolic process | 7.063858e-4 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 7.278896e-4 |
GO:0046605 | regulation of centrosome cycle | 7.402615e-4 |
GO:0000278 | mitotic cell cycle | 7.543268e-4 |
GO:0006713 | glucocorticoid catabolic process | 7.622184e-4 |
GO:0090316 | positive regulation of intracellular protein transport | 8.144112e-4 |
GO:0060389 | pathway-restricted SMAD protein phosphorylation | 8.425765e-4 |
GO:0010468 | regulation of gene expression | 8.684237e-4 |
GO:0046824 | positive regulation of nucleocytoplasmic transport | 9.034662e-4 |
GO:0072215 | regulation of metanephros development | 9.156599e-4 |
GO:0072300 | positive regulation of metanephric glomerulus development | 9.325558e-4 |
GO:2000648 | positive regulation of stem cell proliferation | 9.560206e-4 |
GO:0022007 | convergent extension involved in neural plate elongation | 9.696784e-4 |
GO:0018202 | peptidyl-histidine modification | 9.757156e-4 |
GO:0000255 | allantoin metabolic process | 9.904214e-4 |
GO:0051301 | cell division | 1.006147e-3 |
GO:0060562 | epithelial tube morphogenesis | 1.025281e-3 |
GO:0006303 | double-strand break repair via nonhomologous end joining | 1.027555e-3 |
GO:0032388 | positive regulation of intracellular transport | 1.062029e-3 |
GO:0051252 | regulation of RNA metabolic process | 1.067900e-3 |
GO:0090179 | planar cell polarity pathway involved in neural tube closure | 1.101286e-3 |
GO:0060174 | limb bud formation | 1.135011e-3 |
GO:0060364 | frontal suture morphogenesis | 1.175852e-3 |
GO:0048295 | positive regulation of isotype switching to IgE isotypes | 1.213783e-3 |
GO:0007098 | centrosome cycle | 1.221925e-3 |
GO:0008380 | RNA splicing | 1.224285e-3 |
GO:2001022 | positive regulation of response to DNA damage stimulus | 1.225056e-3 |
GO:0050684 | regulation of mRNA processing | 1.243666e-3 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 1.244399e-3 |
GO:0016458 | gene silencing | 1.282345e-3 |
GO:0000910 | cytokinesis | 1.295075e-3 |
GO:2000602 | regulation of interphase of mitotic cell cycle | 1.313879e-3 |
GO:0070507 | regulation of microtubule cytoskeleton organization | 1.313879e-3 |
GO:0007059 | chromosome segregation | 1.319892e-3 |
GO:0002011 | morphogenesis of an epithelial sheet | 1.326709e-3 |
GO:0051321 | meiotic cell cycle | 1.376023e-3 |
GO:0007023 | post-chaperonin tubulin folding pathway | 1.433202e-3 |
GO:0042360 | vitamin E metabolic process | 1.433202e-3 |
GO:0042473 | outer ear morphogenesis | 1.478316e-3 |
GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process | 1.505629e-3 |
GO:0007140 | male meiosis | 1.528366e-3 |
GO:2000976 | regulation of transcription from RNA polymerase II promoter involved in detection of glucose | 1.539128e-3 |
GO:2000971 | negative regulation of detection of glucose | 1.539128e-3 |
GO:0000433 | negative regulation of transcription from RNA polymerase II promoter by glucose | 1.539128e-3 |
GO:0007052 | mitotic spindle organization | 1.582983e-3 |
GO:0060071 | Wnt receptor signaling pathway, planar cell polarity pathway | 1.671352e-3 |
GO:0060563 | neuroepithelial cell differentiation | 1.692622e-3 |
GO:0060236 | regulation of mitotic spindle organization | 1.734954e-3 |
GO:0043932 | ossification involved in bone remodeling | 1.734954e-3 |
GO:0016070 | RNA metabolic process | 1.742802e-3 |
GO:0035330 | regulation of hippo signaling cascade | 1.754411e-3 |
GO:0007067 | mitosis | 1.758588e-3 |
GO:0014009 | glial cell proliferation | 1.786827e-3 |
GO:0051726 | regulation of cell cycle | 1.823994e-3 |
GO:0051496 | positive regulation of stress fiber assembly | 1.877036e-3 |
GO:0016071 | mRNA metabolic process | 1.894975e-3 |
GO:0046068 | cGMP metabolic process | 1.917944e-3 |
GO:0001832 | blastocyst growth | 1.945461e-3 |
GO:0006352 | transcription initiation, DNA-dependent | 1.979165e-3 |
GO:0090292 | nuclear matrix anchoring at nuclear membrane | 1.986202e-3 |
GO:0042996 | regulation of Golgi to plasma membrane protein transport | 1.986202e-3 |
GO:0060600 | dichotomous subdivision of an epithelial terminal unit | 2.050784e-3 |
GO:0002087 | regulation of respiratory gaseous exchange by neurological system process | 2.101686e-3 |
GO:0007090 | regulation of S phase of mitotic cell cycle | 2.121549e-3 |
GO:0032288 | myelin assembly | 2.220049e-3 |
GO:0043060 | meiotic metaphase I plate congression | 2.329945e-3 |
GO:0040023 | establishment of nucleus localization | 2.351725e-3 |
GO:0006397 | mRNA processing | 2.361347e-3 |
GO:0090307 | spindle assembly involved in mitosis | 2.377652e-3 |
GO:0090193 | positive regulation of glomerulus development | 2.407053e-3 |
GO:0070535 | histone H2A K63-linked ubiquitination | 2.408210e-3 |
GO:0071218 | cellular response to misfolded protein | 2.486074e-3 |
GO:0021998 | neural plate mediolateral regionalization | 2.488625e-3 |
GO:0048352 | paraxial mesoderm structural organization | 2.488625e-3 |
GO:0008208 | C21-steroid hormone catabolic process | 2.488625e-3 |
GO:0048477 | oogenesis | 2.490324e-3 |
GO:0070562 | regulation of vitamin D receptor signaling pathway | 2.498139e-3 |
GO:0010025 | wax biosynthetic process | 2.498139e-3 |
GO:0034764 | positive regulation of transmembrane transport | 2.612852e-3 |
GO:0006268 | DNA unwinding involved in replication | 2.632910e-3 |
GO:0000087 | M phase of mitotic cell cycle | 2.674598e-3 |
GO:0045454 | cell redox homeostasis | 2.708378e-3 |
GO:0007051 | spindle organization | 2.729832e-3 |
GO:0045786 | negative regulation of cell cycle | 2.768776e-3 |
GO:0046039 | GTP metabolic process | 2.833046e-3 |
GO:0051310 | metaphase plate congression | 2.855617e-3 |
GO:0007131 | reciprocal meiotic recombination | 2.880820e-3 |
GO:0042307 | positive regulation of protein import into nucleus | 2.914521e-3 |
GO:0048599 | oocyte development | 2.941288e-3 |
GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway | 2.951180e-3 |
GO:0043488 | regulation of mRNA stability | 3.029286e-3 |
GO:0035194 | posttranscriptional gene silencing by RNA | 3.042469e-3 |
GO:0042053 | regulation of dopamine metabolic process | 3.096876e-3 |
GO:0051382 | kinetochore assembly | 3.098375e-3 |
GO:0042823 | pyridoxal phosphate biosynthetic process | 3.098375e-3 |
GO:0001880 | Mullerian duct regression | 3.113738e-3 |
GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 3.129654e-3 |
GO:0050928 | negative regulation of positive chemotaxis | 3.129654e-3 |
GO:0070846 | Hsp90 deacetylation | 3.129654e-3 |
GO:0090042 | tubulin deacetylation | 3.129654e-3 |
GO:0032543 | mitochondrial translation | 3.129654e-3 |
GO:0000379 | tRNA-type intron splice site recognition and cleavage | 3.129654e-3 |
GO:0019428 | allantoin biosynthetic process | 3.129654e-3 |
GO:0019858 | cytosine metabolic process | 3.129654e-3 |
GO:0010556 | regulation of macromolecule biosynthetic process | 3.158203e-3 |
GO:0060606 | tube closure | 3.168331e-3 |
GO:0009186 | deoxyribonucleoside diphosphate metabolic process | 3.194546e-3 |
GO:0017183 | peptidyl-diphthamide biosynthetic process from peptidyl-histidine | 3.313199e-3 |
GO:0006904 | vesicle docking involved in exocytosis | 3.313395e-3 |
GO:0048665 | neuron fate specification | 3.331422e-3 |
GO:0033084 | regulation of immature T cell proliferation in thymus | 3.383996e-3 |
GO:0045647 | negative regulation of erythrocyte differentiation | 3.400928e-3 |
GO:0032289 | central nervous system myelin formation | 3.411939e-3 |
GO:0002009 | morphogenesis of an epithelium | 3.448056e-3 |
GO:0010564 | regulation of cell cycle process | 3.481776e-3 |
GO:0032571 | response to vitamin K | 3.508146e-3 |
GO:0060425 | lung morphogenesis | 3.602638e-3 |
GO:0035195 | gene silencing by miRNA | 3.638161e-3 |
GO:0007141 | male meiosis I | 3.664103e-3 |
GO:0042424 | catecholamine catabolic process | 3.683894e-3 |
GO:0006116 | NADH oxidation | 3.683894e-3 |
GO:0042069 | regulation of catecholamine metabolic process | 3.760095e-3 |
GO:0001843 | neural tube closure | 3.905774e-3 |
GO:0006654 | phosphatidic acid biosynthetic process | 3.907311e-3 |
GO:0006355 | regulation of transcription, DNA-dependent | 3.913669e-3 |
GO:0043046 | DNA methylation involved in gamete generation | 3.924012e-3 |
GO:0033261 | regulation of S phase | 3.930240e-3 |
GO:0043009 | chordate embryonic development | 3.993760e-3 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 4.031562e-3 |
GO:0048630 | skeletal muscle tissue growth | 4.044282e-3 |
GO:0010659 | cardiac muscle cell apoptosis | 4.052972e-3 |
GO:0002541 | activation of plasma proteins involved in acute inflammatory response | 4.052972e-3 |
GO:0009817 | defense response to fungus, incompatible interaction | 4.052972e-3 |
GO:0055118 | negative regulation of cardiac muscle contraction | 4.185637e-3 |
GO:0006259 | DNA metabolic process | 4.206751e-3 |
GO:0048285 | organelle fission | 4.289841e-3 |
GO:0044065 | regulation of respiratory system process | 4.308961e-3 |
GO:0061304 | retinal blood vessel morphogenesis | 4.348816e-3 |
GO:0008608 | attachment of spindle microtubules to kinetochore | 4.348816e-3 |
GO:2000677 | regulation of transcription regulatory region DNA binding | 4.558878e-3 |
GO:0043487 | regulation of RNA stability | 4.605956e-3 |
GO:0006220 | pyrimidine nucleotide metabolic process | 4.638270e-3 |
GO:0042993 | positive regulation of transcription factor import into nucleus | 4.823843e-3 |
GO:0070936 | protein K48-linked ubiquitination | 4.833820e-3 |
GO:0000209 | protein polyubiquitination | 4.928490e-3 |
GO:0009219 | pyrimidine deoxyribonucleotide metabolic process | 5.060477e-3 |
GO:0046827 | positive regulation of protein export from nucleus | 5.132853e-3 |
GO:0043148 | mitotic spindle stabilization | 5.146734e-3 |
GO:0007389 | pattern specification process | 5.152754e-3 |
GO:0070918 | production of small RNA involved in gene silencing by RNA | 5.156108e-3 |
GO:0051171 | regulation of nitrogen compound metabolic process | 5.250731e-3 |
GO:0071173 | spindle assembly checkpoint | 5.271314e-3 |
GO:0010608 | posttranscriptional regulation of gene expression | 5.306910e-3 |
GO:0006730 | one-carbon metabolic process | 5.332233e-3 |
GO:0003357 | noradrenergic neuron differentiation | 5.424195e-3 |
GO:0034968 | histone lysine methylation | 5.513437e-3 |
GO:0006651 | diacylglycerol biosynthetic process | 5.627999e-3 |
GO:0030262 | apoptotic nuclear change | 5.656280e-3 |
GO:0046164 | alcohol catabolic process | 5.663539e-3 |
GO:0009081 | branched chain family amino acid metabolic process | 5.752189e-3 |
GO:0051058 | negative regulation of small GTPase mediated signal transduction | 5.762573e-3 |
GO:2000344 | positive regulation of acrosome reaction | 5.818692e-3 |
GO:0070192 | chromosome organization involved in meiosis | 5.935161e-3 |
GO:0019320 | hexose catabolic process | 5.959020e-3 |
GO:0045143 | homologous chromosome segregation | 6.011328e-3 |
GO:0009994 | oocyte differentiation | 6.057043e-3 |
GO:0070163 | regulation of adiponectin secretion | 6.155250e-3 |
GO:0007196 | inhibition of adenylate cyclase activity by metabotropic glutamate receptor signaling pathway | 6.155250e-3 |
GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 6.171295e-3 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 6.254165e-3 |
GO:0072368 | regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter | 6.261230e-3 |
GO:0072362 | regulation of glycolysis by negative regulation of transcription from RNA polymerase II promoter | 6.261230e-3 |
GO:0006931 | substrate-dependent cell migration, cell attachment to substrate | 6.261230e-3 |
GO:0046580 | negative regulation of Ras protein signal transduction | 6.299394e-3 |
GO:0035481 | positive regulation of Notch signaling pathway involved in heart induction | 6.345232e-3 |
GO:0042667 | auditory receptor cell fate specification | 6.345232e-3 |
GO:0014895 | smooth muscle hypertrophy | 6.345232e-3 |
GO:0045609 | positive regulation of auditory receptor cell differentiation | 6.345232e-3 |
GO:0060975 | cardioblast migration to the midline involved in heart field formation | 6.345232e-3 |
GO:0003106 | negative regulation of glomerular filtration by angiotensin | 6.345232e-3 |
GO:0009438 | methylglyoxal metabolic process | 6.345232e-3 |
GO:0003210 | cardiac atrium formation | 6.345232e-3 |
GO:0003259 | cardioblast anterior-lateral migration | 6.345232e-3 |
GO:0003236 | sinus venosus morphogenesis | 6.345232e-3 |
GO:0007050 | cell cycle arrest | 6.427692e-3 |
GO:0060441 | epithelial tube branching involved in lung morphogenesis | 6.448931e-3 |
GO:0044260 | cellular macromolecule metabolic process | 6.488268e-3 |
GO:0002268 | follicular dendritic cell differentiation | 6.488636e-3 |
GO:0031577 | spindle checkpoint | 6.528231e-3 |
GO:0010467 | gene expression | 6.597097e-3 |
GO:0048278 | vesicle docking | 6.667013e-3 |
GO:0033083 | regulation of immature T cell proliferation | 6.692635e-3 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 6.742439e-3 |
GO:0035567 | non-canonical Wnt receptor signaling pathway | 6.747859e-3 |
GO:0051568 | histone H3-K4 methylation | 6.805584e-3 |
GO:0016197 | endosome transport | 6.951615e-3 |
GO:0006308 | DNA catabolic process | 7.007404e-3 |
GO:0045814 | negative regulation of gene expression, epigenetic | 7.017958e-3 |
GO:0006098 | pentose-phosphate shunt | 7.064511e-3 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 7.188166e-3 |
GO:0016075 | rRNA catabolic process | 7.188166e-3 |
GO:0014020 | primary neural tube formation | 7.205374e-3 |
GO:0007126 | meiosis | 7.244605e-3 |
GO:0048663 | neuron fate commitment | 7.320300e-3 |
GO:0014067 | negative regulation of phosphatidylinositol 3-kinase cascade | 7.494484e-3 |
GO:0006184 | GTP catabolic process | 7.764164e-3 |
GO:0070634 | transepithelial ammonium transport | 7.790155e-3 |
GO:0072124 | regulation of glomerular mesangial cell proliferation | 7.839173e-3 |
GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation | 7.891432e-3 |
GO:0035196 | production of miRNAs involved in gene silencing by miRNA | 7.907491e-3 |
GO:0046069 | cGMP catabolic process | 7.922117e-3 |
GO:0016180 | snRNA processing | 7.922117e-3 |
GO:0070534 | protein K63-linked ubiquitination | 7.979897e-3 |
GO:0051656 | establishment of organelle localization | 7.987086e-3 |
GO:0072488 | ammonium transmembrane transport | 8.103883e-3 |
GO:0060376 | positive regulation of mast cell differentiation | 8.329761e-3 |
GO:0008611 | ether lipid biosynthetic process | 8.329761e-3 |
GO:0002537 | nitric oxide production involved in inflammatory response | 8.329761e-3 |
GO:0010225 | response to UV-C | 8.460511e-3 |
GO:0006260 | DNA replication | 8.465528e-3 |
GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry | 8.553446e-3 |
GO:0051313 | attachment of spindle microtubules to chromosome | 8.603153e-3 |
GO:0048387 | negative regulation of retinoic acid receptor signaling pathway | 8.634695e-3 |
GO:0010002 | cardioblast differentiation | 8.845614e-3 |
GO:0051303 | establishment of chromosome localization | 8.931236e-3 |
GO:0051169 | nuclear transport | 8.997445e-3 |
GO:0031047 | gene silencing by RNA | 9.054794e-3 |
GO:0006086 | acetyl-CoA biosynthetic process from pyruvate | 9.068671e-3 |
GO:0090234 | regulation of kinetochore assembly | 9.098365e-3 |
GO:0090169 | regulation of spindle assembly | 9.098365e-3 |
GO:0001705 | ectoderm formation | 9.098365e-3 |
GO:0002030 | inhibitory G-protein coupled receptor phosphorylation | 9.098365e-3 |
GO:0007060 | male meiosis chromosome segregation | 9.098365e-3 |
GO:0032229 | negative regulation of synaptic transmission, GABAergic | 9.184412e-3 |
GO:0006450 | regulation of translational fidelity | 9.400437e-3 |
GO:0048026 | positive regulation of nuclear mRNA splicing, via spliceosome | 9.429530e-3 |
GO:0006346 | methylation-dependent chromatin silencing | 9.429530e-3 |
GO:0009792 | embryo development ending in birth or egg hatching | 9.451138e-3 |
GO:0043001 | Golgi to plasma membrane protein transport | 9.960257e-3 |
GO:0045014 | negative regulation of transcription by glucose | 1.001921e-2 |
GO:0006515 | misfolded or incompletely synthesized protein catabolic process | 1.001921e-2 |
GO:0032914 | positive regulation of transforming growth factor beta1 production | 1.008102e-2 |
GO:0006921 | cellular component disassembly involved in apoptosis | 1.011850e-2 |
GO:0045880 | positive regulation of smoothened signaling pathway | 1.017691e-2 |
GO:0045084 | positive regulation of interleukin-12 biosynthetic process | 1.031250e-2 |
GO:0034587 | piRNA metabolic process | 1.055067e-2 |
GO:0032508 | DNA duplex unwinding | 1.060413e-2 |
GO:0032981 | mitochondrial respiratory chain complex I assembly | 1.060860e-2 |
GO:0042761 | very long-chain fatty acid biosynthetic process | 1.071266e-2 |
GO:0060466 | activation of meiosis involved in egg activation | 1.076443e-2 |
GO:0009452 | RNA capping | 1.076443e-2 |
GO:0050774 | negative regulation of dendrite morphogenesis | 1.076443e-2 |
GO:2000001 | regulation of DNA damage checkpoint | 1.076786e-2 |
GO:0070368 | positive regulation of hepatocyte differentiation | 1.076786e-2 |
GO:0031268 | pseudopodium organization | 1.076786e-2 |
GO:0014805 | smooth muscle adaptation | 1.076786e-2 |
GO:0043271 | negative regulation of ion transport | 1.080366e-2 |
GO:0071479 | cellular response to ionizing radiation | 1.085212e-2 |
GO:0006401 | RNA catabolic process | 1.095554e-2 |
GO:0042345 | regulation of NF-kappaB import into nucleus | 1.109736e-2 |
GO:0032727 | positive regulation of interferon-alpha production | 1.110147e-2 |
GO:0002513 | tolerance induction to self antigen | 1.110147e-2 |
GO:0055119 | relaxation of cardiac muscle | 1.131033e-2 |
GO:0006729 | tetrahydrobiopterin biosynthetic process | 1.131033e-2 |
GO:0007127 | meiosis I | 1.147189e-2 |
GO:0002089 | lens morphogenesis in camera-type eye | 1.147189e-2 |
GO:0006913 | nucleocytoplasmic transport | 1.157392e-2 |
GO:0032845 | negative regulation of homeostatic process | 1.159731e-2 |
GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching | 1.171952e-2 |
GO:0060437 | lung growth | 1.174000e-2 |
GO:0048025 | negative regulation of nuclear mRNA splicing, via spliceosome | 1.174000e-2 |
GO:0033683 | nucleotide-excision repair, DNA incision | 1.205789e-2 |
GO:0060028 | convergent extension involved in axis elongation | 1.205789e-2 |
GO:0033132 | negative regulation of glucokinase activity | 1.205789e-2 |
GO:0019405 | alditol catabolic process | 1.205789e-2 |
GO:0016073 | snRNA metabolic process | 1.207634e-2 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 1.226024e-2 |
GO:0072513 | positive regulation of secondary heart field cardioblast proliferation | 1.226943e-2 |
GO:0006417 | regulation of translation | 1.234666e-2 |
GO:0045132 | meiotic chromosome segregation | 1.260746e-2 |
GO:0035721 | intraflagellar retrograde transport | 1.269762e-2 |
GO:0017187 | peptidyl-glutamic acid carboxylation | 1.269762e-2 |
GO:0061015 | snRNA import into nucleus | 1.269762e-2 |
GO:0009443 | pyridoxal 5'-phosphate salvage | 1.269762e-2 |
GO:0006683 | galactosylceramide catabolic process | 1.269762e-2 |
GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 1.271061e-2 |
GO:0018120 | peptidyl-arginine ADP-ribosylation | 1.271061e-2 |
GO:0000075 | cell cycle checkpoint | 1.271329e-2 |
GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 1.282244e-2 |
GO:0051383 | kinetochore organization | 1.282244e-2 |
GO:0046501 | protoporphyrinogen IX metabolic process | 1.282244e-2 |
GO:0051584 | regulation of dopamine uptake | 1.299329e-2 |
GO:0034508 | centromere complex assembly | 1.299329e-2 |
GO:0090212 | negative regulation of establishment of blood-brain barrier | 1.301420e-2 |
GO:2000781 | positive regulation of double-strand break repair | 1.301420e-2 |
GO:0015969 | guanosine tetraphosphate metabolic process | 1.301420e-2 |
GO:2000299 | negative regulation of Rho-dependent protein serine/threonine kinase activity | 1.301420e-2 |
GO:0090168 | Golgi reassembly | 1.301420e-2 |
GO:0001546 | preantral ovarian follicle growth | 1.301420e-2 |
GO:0014853 | regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction | 1.301420e-2 |
GO:0007100 | mitotic centrosome separation | 1.301420e-2 |
GO:0009236 | cobalamin biosynthetic process | 1.301420e-2 |
GO:0007506 | gonadal mesoderm development | 1.301420e-2 |
GO:0001710 | mesodermal cell fate commitment | 1.301878e-2 |
GO:0035520 | monoubiquitinated protein deubiquitination | 1.317081e-2 |
GO:0032525 | somite rostral/caudal axis specification | 1.351671e-2 |
GO:0042474 | middle ear morphogenesis | 1.353746e-2 |
GO:0031345 | negative regulation of cell projection organization | 1.394140e-2 |
GO:0072110 | glomerular mesangial cell proliferation | 1.395486e-2 |
GO:0048755 | branching morphogenesis of a nerve | 1.395486e-2 |
GO:0070734 | histone H3-K27 methylation | 1.395486e-2 |
GO:0015879 | carnitine transport | 1.395486e-2 |
GO:0045116 | protein neddylation | 1.395486e-2 |
GO:0032392 | DNA geometric change | 1.396925e-2 |
GO:0007431 | salivary gland development | 1.401307e-2 |
GO:0033157 | regulation of intracellular protein transport | 1.406763e-2 |
GO:0006573 | valine metabolic process | 1.418399e-2 |
GO:0046544 | development of secondary male sexual characteristics | 1.418449e-2 |
GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly | 1.418449e-2 |
GO:0006007 | glucose catabolic process | 1.435091e-2 |
GO:0030307 | positive regulation of cell growth | 1.449907e-2 |
GO:0000070 | mitotic sister chromatid segregation | 1.461810e-2 |
GO:0002053 | positive regulation of mesenchymal cell proliferation | 1.542488e-2 |
GO:0006304 | DNA modification | 1.565442e-2 |
GO:0043653 | mitochondrial fragmentation involved in apoptosis | 1.567859e-2 |
GO:0035441 | cell migration involved in vasculogenesis | 1.567859e-2 |
GO:0034453 | microtubule anchoring | 1.570448e-2 |
GO:0032020 | ISG15-protein conjugation | 1.582361e-2 |
GO:0051386 | regulation of nerve growth factor receptor signaling pathway | 1.594218e-2 |
GO:0051320 | S phase | 1.594218e-2 |
GO:0042119 | neutrophil activation | 1.594218e-2 |
GO:0002072 | optic cup morphogenesis involved in camera-type eye development | 1.594856e-2 |
GO:0009133 | nucleoside diphosphate biosynthetic process | 1.617220e-2 |
GO:0033239 | negative regulation of cellular amine metabolic process | 1.629253e-2 |
GO:0033233 | regulation of protein sumoylation | 1.633955e-2 |
GO:0046365 | monosaccharide catabolic process | 1.640499e-2 |
GO:0045066 | regulatory T cell differentiation | 1.642858e-2 |
GO:0015696 | ammonium transport | 1.642858e-2 |
GO:0072091 | regulation of stem cell proliferation | 1.643754e-2 |
GO:0006309 | DNA fragmentation involved in apoptotic nuclear change | 1.643754e-2 |
GO:0048385 | regulation of retinoic acid receptor signaling pathway | 1.656857e-2 |
GO:0048536 | spleen development | 1.679080e-2 |
GO:0021695 | cerebellar cortex development | 1.692097e-2 |
GO:0033092 | positive regulation of immature T cell proliferation in thymus | 1.704433e-2 |
GO:0016480 | negative regulation of transcription from RNA polymerase III promoter | 1.707332e-2 |
GO:0045759 | negative regulation of action potential | 1.707332e-2 |
GO:0000729 | DNA double-strand break processing | 1.707332e-2 |
GO:0000414 | regulation of histone H3-K36 methylation | 1.707332e-2 |
GO:0032507 | maintenance of protein location in cell | 1.711377e-2 |
GO:0030497 | fatty acid elongation | 1.720411e-2 |
GO:0006997 | nucleus organization | 1.721826e-2 |
GO:0045064 | T-helper 2 cell differentiation | 1.727901e-2 |
GO:0071585 | detoxification of cadmium ion | 1.727901e-2 |
GO:0032456 | endocytic recycling | 1.732816e-2 |
GO:0043114 | regulation of vascular permeability | 1.784791e-2 |
GO:0006269 | DNA replication, synthesis of RNA primer | 1.786397e-2 |
GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter | 1.791679e-2 |
GO:0072361 | regulation of glycolysis by regulation of transcription from RNA polymerase II promoter | 1.791679e-2 |
GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway | 1.814723e-2 |
GO:0032608 | interferon-beta production | 1.814723e-2 |
GO:0046092 | deoxycytidine metabolic process | 1.814723e-2 |
GO:0000080 | G1 phase of mitotic cell cycle | 1.839330e-2 |
GO:2000778 | positive regulation of interleukin-6 secretion | 1.848237e-2 |
GO:0061301 | cerebellum vasculature morphogenesis | 1.848237e-2 |
GO:0030421 | defecation | 1.848237e-2 |
GO:0051466 | positive regulation of corticotropin-releasing hormone secretion | 1.848237e-2 |
GO:0071174 | mitotic cell cycle spindle checkpoint | 1.850381e-2 |
GO:0051318 | G1 phase | 1.854423e-2 |
GO:0034661 | ncRNA catabolic process | 1.873947e-2 |
GO:0009451 | RNA modification | 1.914799e-2 |
GO:0007030 | Golgi organization | 1.918185e-2 |
GO:0014032 | neural crest cell development | 1.921453e-2 |
GO:0010457 | centriole-centriole cohesion | 1.947706e-2 |
GO:0007129 | synapsis | 1.949225e-2 |
GO:0090183 | regulation of kidney development | 1.953250e-2 |
GO:0051642 | centrosome localization | 1.986361e-2 |
GO:0050680 | negative regulation of epithelial cell proliferation | 1.999296e-2 |
GO:0033578 | protein glycosylation in Golgi | 2.003643e-2 |
GO:0070102 | interleukin-6-mediated signaling pathway | 2.003888e-2 |
GO:0032825 | positive regulation of natural killer cell differentiation | 2.003888e-2 |
GO:0017145 | stem cell division | 2.043119e-2 |
GO:0022406 | membrane docking | 2.043851e-2 |
GO:0048484 | enteric nervous system development | 2.051244e-2 |